We were delighted to catch up with Prof Daniel Kelly (Cardiff University, Wales, UK) to discuss the latest policy developments in the mission of HPV cancer elimination and the gender neutral vaccination plan.
1. How are the World Health Organisation and Europe’s Beating Cancer Plan working together to tackle HPV-associated cancers? (00:20-01:18)
2. What has been the impact of the HPV vaccine in terms of cancer prevention? (01:18-02:28)
3. What are the hopes for gender neutral vaccination? (02:28-03:38)
4. Could you tell us a little about the European Cancer Organisation’s HPV Action Network and its aims? (03:38-04:43)
5. How is the HPV Action Network working to improve gender neutral vaccination availability across Europe? (04:43-05:47)
Speaker Disclosure: Daniel Kelly has no financial or non-financial conflicts of interest to declare in relation to this video.
Support: Interview and filming supported by Touch Medical Media Ltd. Interview conducted by Sophie Nickelson.
Filmed in coverage of the European Cancer Summit 2021
Share this Video
Related Videos In Policy
Mark Lawler, European Cancer Summit 2022: The ECO-ASCO Special Network
The impact of the Russian invasion on Ukraine and how this has impacted clinical trials and cancer care in Europe. The Special Network on the Impact of the War in Ukraine on Cancer was established by ECO Board and ASCO soon after the war started, and now has representatives of over 300 organisations. In this […]
Mark Lawler, European Cancer Summit, 2022: What is the European Cancer Pulse?
Professor Mark Lawler (Queen’s University Belfast) summarizes the European Cancer Pulse, an exciting new tool that brings together data from 34 European countries and helps determine cancer care disparities on cancer burden, research spending, prevention efforts, early detection, diagnosis and treatment access, survivorship, impact of social determinants and much more. For more information, click here. […]
Mark Lawler, European Cancer Summit 2022: The European Groundshot
The European Groundshot—addressing Europe’s cancer research challenges: a Lancet Oncology Commission is a unique imitative launched this year aims to identify the challenges in cancer care in Europe. The COVID-19 pandemic has had a significant impact on cancer diagnosis and halted many ongoing clinical trials. In this video, Professor Mark Lawler (Queen’s University Belfast) describes […]
Journal articles and more to your inbox
Get the latest clinical insights from touchONCOLOGYSign me up!